Joseph Bratica
2020
Compensation breakdown
| Non-Equity Incentive Plan | $100,840 |
|---|---|
| Option Awards | $235,848 |
| Salary | $326,028 |
| Stock Awards | $237,525 |
| Other | $11,645 |
| Total | $911,887 |
Bratica received $326K in salary, accounting for 36% of the total pay in 2020.
Bratica also received $100.8K in non-equity incentive plan, $235.8K in option awards, $237.5K in stock awards and $11.6K in other compensation.
Rankings
In 2020, Joseph Bratica's compensation ranked 9,003rd out of 13,090 executives tracked by ExecPay. In other words, Bratica earned more than 31.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,003 out of 13,090 | 31st |
Division Manufacturing | 3,846 out of 5,618 | 32nd |
Major group Chemicals And Allied Products | 1,553 out of 2,251 | 31st |
Industry group Drugs | 1,356 out of 1,951 | 31st |
Industry Pharmaceutical Preparations | 1,004 out of 1,456 | 31st |
Pay ratio
| Joseph Bratica's Pay | $911,887 |
|---|---|
| Median Employee's Pay | $275,247 |
| Pay Ratio | 3to 1 |
In 2020, the annual total compensation of Joseph Bratica was $911,887.
The annual total compensation of the median employee at Sarepta Therapeutics was $275,247.
The ratio of Joseph Bratica's pay to the pay of median employee was therefore 3 to one.
Bratica's colleagues
We found seven more compensation records of executives who worked with Joseph Bratica at Sarepta Therapeutics in 2020.
2020
Louise Rodino-Klapac
Sarepta Therapeutics
Chief Scientific Officer
2020
David Howton
Sarepta Therapeutics
General Counsel
2020
Ian Estepan
Sarepta Therapeutics
Chief Financial Officer
2020
Gilmore MMSc
Sarepta Therapeutics
Chief Scientific Officer
2020
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2020
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
2020
William Ciambrone
Sarepta Therapeutics